A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression

Journal of Clinical Psychiatry

Volumn 59, Issue 3, 1998, Pages 116-122

  Rudolph, Richard L ^a,e   Fabre, Louis F ^b   Feighner, John P ^c   Rickels, Karl ^d   Entsuah, Richard ^a   Derivan, Albert T ^a  

^a WYETH AYERST RESEARCH   (United States)

^b Fabre Research Clinic Inc   (United States)

^c Feighner Research Institute   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORAL HYDRATE; VENLAFAXINE;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VERTIGO; XEROSTOMIA;

EID: 0031942196     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0305     Document Type: Article

References (10)

1. Muth EA, Haskins JT, Husbands GE, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-4497
2. Goldberg HL, Finnerty R. An open-label, variable-dose study of Wy-45,030 (venlafaxine) in depressed patients. Psychopharmacol Bull 1988;24:198-199
3. Schweizer E, Clary C, Weise C, et al. An open-label, dose-finding study of Wy-45,030, a novel bicyclic antidepressant. Psychopharmacol Bull 1988; 24:195-197
4. Khan A, Fabre LF, Rudolph R. Venlafaxine in depressed outpatients. Psychopharmacol Bull 1991;27:141-144
5. Schweizer E, Weise C, Clary C, et al. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991; 11:233-236
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition. Washington, DC: American Psychiatric Association; 1980:97-101
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
8. Montgomery SA, Asberg M. A new depression rating scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
9. Jonckheere AR. A distribution-free K-sample test against ordered alternatives. Biometrika 1954;41:133-145
10. Nelson CJ, Mazure CM, Bowers MB Jr, et al. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991;48:303-307